Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05207033 · ClinicalTrials.gov registry record · NA

Responses to Regulated E-Cigarette Advertisements

A NA study of Tobacco Use, sponsored by University of Massachusetts, Worcester.

Completed
Registry status
NA
Development phase
195
Enrollment target
1
Study location

NCT05207033 is a NA study of Tobacco Use that has completed, run by University of Massachusetts, Worcester. The registered enrollment target is 195 participants, below the 376-participant average among 76 other Tobacco Use trials with a reported enrollment target (48% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05207033, a NA study of Tobacco Use, has completed, sponsored by University of Massachusetts, Worcester.

COMPLETED
Registry status
NA
Development phase
195 participants
Enrollment target
1
Study location

Study Summary

While conventional cigarette use continues to decline among youth and young adults, e-cigarette (EC) use is on the rise. Specifically, the investigators will conduct a randomized control trial (RCT) where young adults are randomized to one of two conditions: 1) a regulated ad environment, with high impact EC ad features removed or 2) an unregulated ad environment, with high impact EC ad features left intact. Participants will view EC ads embedded in an online magazine 24 times over the course of 6 months. EC experimentation and sustained use will be the primary outcome of interest.

Conditions Studied

Interventions

  • OTHER Regulated ad condition
  • OTHER Unregulated ad condition

Study Locations (1)

Massachusetts

  • UMass Chan Medical School Stevens Lab - Worcester

Trial Details

FieldValue
Enrollment Target 195 participants
Start Date 2022-04-01
Est. Completion 2024-07-01
Phase NA

What the Registry Record Tells You About NCT05207033

The ClinicalTrials.gov registry entry for NCT05207033 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 195 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 376-participant average among 76 other Tobacco Use trials with a reported enrollment target (48% lower). The listed sponsor is University of Massachusetts, Worcester, which has 240 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Tobacco Use appearing as the primary indexed condition, and to 2 interventions - of which Regulated ad condition is the first listed.

NCT05207033 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.

Frequently Asked Questions

What is clinical trial NCT05207033 about?

NCT05207033 is a clinical study titled "Responses to Regulated E-Cigarette Advertisements". While conventional cigarette use continues to decline among youth and young adults, e-cigarette (EC) use is on the rise. Specifically, the investigators will conduct a randomized control trial (RCT) where young adults are randomized to one of two conditions: 1) a regulated ad environment, with high ...

What is the current status of trial NCT05207033?

This trial is currently completed. It is a NA study. The enrollment target is 195 participants. The study started on 2022-04-01. Estimated completion is 2024-07-01.

What conditions does trial NCT05207033 study?

This clinical trial studies the following conditions: Tobacco Use.

What interventions are being tested in trial NCT05207033?

The interventions under investigation include: Regulated ad condition (OTHER), Unregulated ad condition (OTHER).

Who is sponsoring clinical trial NCT05207033?

This trial is sponsored by University of Massachusetts, Worcester, which has 240 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05207033 being conducted?

This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Tobacco Use

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.